SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-010114
Filing Date
2017-05-10
Accepted
2017-05-10 11:35:50
Documents
50
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 Q1 2017 10_Q 03312017 vsar-10q_20170331.htm 10-Q 1188662
2 EX-10.1 vsar-ex101_236.htm EX-10.1 344391
3 EX-31.1 vsar-ex311_8.htm EX-31.1 16720
4 EX-31.2 vsar-ex312_7.htm EX-31.2 16474
5 EX-32.1 vsar-ex321_6.htm EX-32.1 5174
  Complete submission text file 0001564590-17-010114.txt   3911397

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT vsar-20170331.xml EX-101.INS 596284
7 XBRL TAXONOMY EXTENSION SCHEMA vsar-20170331.xsd EX-101.SCH 32968
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vsar-20170331_cal.xml EX-101.CAL 31275
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vsar-20170331_def.xml EX-101.DEF 68555
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE vsar-20170331_lab.xml EX-101.LAB 223240
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vsar-20170331_pre.xml EX-101.PRE 156707
Mailing Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025
Business Address 4200 BOHANNON DRIVE SUITE 250 MENLO PARK CA 94025 6509638580
Versartis, Inc. (Filer) CIK: 0001513818 (see all company filings)

IRS No.: 264106690 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36361 | Film No.: 17829111
SIC: 2834 Pharmaceutical Preparations